The Short Answer Educational content only, not medical advice. No test described here diagnoses concussion on its own, and concussion diagnosis remains clinical. The advanced imaging methods covered in this series are research tools that detect group-level differences and are not validated to diagnose or exclude concussion in an individual person. Be cautious about clinics selling scans or brain maps as diagnostic. Discuss any assessment with a concussion-experienced clinician who can interpret it alongside your history and examination. PET imaging injects a radioactive tracer designed to bind to a specific target, then detects where it accumulates, allowing measurement of glucose metabolism, tau protein deposition, or markers of neuroinflammation depending on which tracer is used. In chronic post-concussion syndrome all three applications are research rather than clinical. The most publicized is tau PET, studied for detecting chronic traumatic encephalopathy during life, and a major research project was designed specifically to develop and evaluate methods for that purpose (Alosco et al., 2021). That work is ongoing, and PET cannot currently diagnose chronic traumatic encephalopathy in a living person. The tracer determines what is measured: metabolism, tau, or inflammation. Tau PET for detecting CTE in life is under active research, not established. PET involves radiation exposure, unlike the MRI-based methods. The Three Main Applications FDG-PET uses a glucose analog to map where the brain consumes energy, and it is the oldest application. Studies in chronic symptoms after brain injury report regional hypometabolism, particularly in frontal and temporal regions, though findings overlap substantially with depression, chronic pain, and sleep disorders. Tau PET uses tracers binding to abnormal tau protein, the pathology defining chronic traumatic encephalopathy. TSPO PET targets a protein upregulated in activated microglia, providing a marker of neuroinflammation, which is of interest because persistent neuroinflammation is one proposed mechanism for prolonged symptoms. The Tau PET and CTE Question Chronic traumatic encephalopathy is currently diagnosed only at autopsy, by identifying a specific pattern of tau accumulation around small blood vessels at the depths of cortical sulci. Developing an in-life diagnosis is the central challenge, and a substantial research project was designed with that explicit aim, evaluating tau PET alongside other biomarkers in former contact sport athletes (Alosco et al., 2021). The obstacles are considerable. Available tau tracers were developed for Alzheimer disease tau, which differs in conformation and distribution from the tau in chronic traumatic encephalopathy, so binding characteristics are uncertain. Why Interpretation Is Difficult Specificity is the core problem across all three tracer types. Reduced glucose metabolism appears in depression, chronic pain, sleep deprivation, and medication effects, all common in this population, so hypometabolism does not identify concussion as the cause. Tau accumulates in aging and in several neurodegenerative conditions. Neuroinflammation markers rise in many circumstances. Additionally, symptoms in chronic post-concussion syndrome frequently arise from vestibular, cervical, visual, autonomic, sleep, and mood mechanisms that PET does not measure at all, so a finding may be present and irrelevant to the person's actual complaints. The Radiation Consideration PET differs from every other method in this series by involving ionizing radiation, with a typical brain scan delivering a dose in the range of several millisieverts depending on tracer and protocol. That is a modest exposure and a real one, and it changes the risk calculation compared with MRI-based methods carrying no such cost. It makes serial scanning less appropriate and means the threshold for scanning should be higher. Anyone offered PET for concussion should ask specifically what the result would change about their treatment, since a scan with radiation exposure and no management consequence is a poor trade. Where This Leaves Patients For someone with chronic post-concussion symptoms, PET is not a route to answers at present. The research is genuinely important, particularly the effort to enable in-life diagnosis of chronic traumatic encephalopathy, and it has not yet produced a clinically usable test. Broader reviews place PET alongside the other advanced methods as informative about mechanism rather than validated for individual diagnosis (Maas et al., 2022). Persistent symptoms are far more often explained by treatable vestibular, cervical, visual, sleep, and mood contributors, and identifying those changes outcomes in a way a scan does not (Silverberg et al., 2020). Assessment identifies what is driving symptoms. Cervical and vestibular contributors are among the most commonly found and the most treatable. Start your 3-day free trial for joint-specific mobility programming addressing the neck side of those findings. Supporting Mobility Routine JME 14 Chin tucks reduce the upper cervical tension driving cervicogenic headache, one of the most common findings on post-concussion assessment. Ten repetitions with 5-second holds. JME 1 Cervical rotation restores segmental mobility, which is directly relevant where assessment identifies a cervical contribution to dizziness. Ten repetitions per direction. JME 15 Cervical lateral flexion addresses side-bending restriction sustaining neck tension and headache. Ten repetitions per side. JME 16 Cervical flexion and extension restore sagittal mobility restricted by suboccipital guarding after impact. Eight slow repetitions. JME 2 Cervical retraction reinforces a neutral head position, reducing the postural strain that worsens symptoms during screen-based testing. Ten repetitions per set. JME 150 Thoracic rotation restores mid-back motion, which reduces compensatory load on the cervical spine. Eight repetitions per direction. JME 227 Overhead reach opens the thoracic spine and rib cage, supporting the breathing mechanics behind nervous system regulation. Ten repetitions with controlled tempo. JME 155 Diaphragmatic breathing lowers sympathetic drive, which reduces the symptom load that degrades performance on any cognitive assessment. Ten slow breaths, several times daily. Start your 3-day free trial for joint-specific mobility programming addressing the cervical contributors assessment identifies. Common Mistakes Seeking PET to confirm or exclude chronic traumatic encephalopathy Reading hypometabolism as specific to brain injury Overlooking depression, pain, and sleep disruption as causes of the same finding Accepting radiation exposure without a clear management consequence Assuming tau tracers developed for Alzheimer disease bind CTE tau reliably Pursuing PET before vestibular, cervical, and mood assessment Treating a research finding as an individual diagnosis Progression Begin with clinical assessment identifying treatable vestibular, cervical, visual, sleep, mood, and autonomic contributors, which explain most chronic symptoms and respond to targeted treatment. Where cognitive complaints dominate, formal neuropsychological assessment gives actionable information. Treat PET as a research method, and where offered, ask what the result would change about treatment before accepting radiation exposure. Research participation is a reasonable route for those wanting to contribute to the in-life diagnosis effort. What does PET measure in chronic post-concussion syndrome? It depends on the tracer. FDG measures regional glucose metabolism, tau tracers target abnormal tau protein deposition, and TSPO tracers mark activated microglia as an indicator of neuroinflammation. All three applications are research rather than clinical in this context. Can PET diagnose chronic traumatic encephalopathy? No. CTE is currently diagnosed only at autopsy through a specific pattern of tau accumulation. Research projects have been designed explicitly to develop in-life detection methods, and that work is ongoing rather than resolved. Why is tau PET difficult for CTE? Available tau tracers were developed for Alzheimer disease tau, which differs in conformation and distribution from CTE tau, so binding characteristics are uncertain. Tau also accumulates in normal aging and other neurodegenerative conditions, which limits specificity. What else causes reduced glucose metabolism on PET? Depression, chronic pain, sleep deprivation, and various medications all reduce regional glucose metabolism, and all are common alongside chronic post-concussion symptoms. Hypometabolism therefore does not identify brain injury as the cause. Does PET involve radiation? Yes, unlike the MRI-based methods. A brain PET delivers a dose of several millisieverts depending on tracer and protocol, which is modest and real. That makes serial scanning less appropriate and raises the threshold for scanning without a clear management consequence. How These Tools Fit Together Concussion diagnosis is clinical. It rests on the injury mechanism, the symptoms, and the examination, and international consensus guidance is explicit that no single test establishes or excludes the diagnosis (Patricios et al., 2023). Everything described in this series sits in a supporting role. Sideline and clinic tools such as SCAT6, VOMS, and King-Devick add structure and reproducibility to the clinical assessment. Computerized cognitive batteries quantify one specific domain. Advanced imaging methods detect group-level differences in research populations and are not validated for individual diagnosis (Maas et al., 2022). Confusing these roles is the most common error patients and clinicians make. What Assessment Is Actually For Confirming a clinical picture already suspected from history and examination Identifying which subtype is driving symptoms: vestibular, ocular, cervical, mood, sleep, or migraine Tracking change over time against the person's own earlier results Supporting return-to-play and return-to-work decisions with objective data Ruling out structural injury needing emergency treatment, which is what standard CT does Directing treatment toward the specific system involved Documenting recovery for insurance, legal, or occupational purposes Why Advanced Imaging Is Not Diagnostic Yet The barrier is not that these methods detect nothing. Diffusion imaging, functional MRI, magnetoencephalography, spectroscopy, and perfusion imaging all show reproducible group differences between concussed and control populations. The barrier is the gap between a group difference and an individual diagnosis. Concussion effects are small relative to normal human variation, findings differ in direction between studies and time points, most research lacks pre-injury baselines, acquisition and analysis methods vary between centers, and few studies report the sensitivity and specificity needed to classify one person (Lindsey et al., 2023, and Mayer et al., 2015). A test cannot be clinically diagnostic until it performs reliably on a single scan against a validated normative reference, and that threshold has not been met. Questions Worth Asking About Any Test Several questions separate useful assessment from expensive noise. Does the result change treatment, or only produce a label. Is there a baseline or normative comparison appropriate to your age, sex, and background. What are the sensitivity and specificity for individual diagnosis, and does the provider quote them. Would a concussion-experienced clinician interpret this alongside examination findings, or is it delivered as a standalone report. Is the test being sold directly to patients outside standard clinical pathways. Persistent symptoms usually reflect treatable vestibular, cervical, visual, sleep, or mood problems, and identifying those through clinical assessment changes management in a way most advanced imaging currently does not (Silverberg et al., 2020). References Patricios, J. S., Schneider, K. J., Dvorak, J., et al. (2023). Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport, Amsterdam, October 2022. British Journal of Sports Medicine, 57(11), 695-711. PubMed Echemendia, R. J., Brett, B. L., Broglio, S., et al. (2023). Sport Concussion Assessment Tool 6 (SCAT6). British Journal of Sports Medicine, 57(11), 622-631. PubMed Mucha, A., Collins, M. W., Elbin, R. J., et al. (2014). A brief Vestibular/Ocular Motor Screening (VOMS) assessment to evaluate concussions: preliminary findings. American Journal of Sports Medicine, 42(10), 2479-2486. PubMed Krause, D. A., Hollman, J. H., Breuer, L. T., et al. (2022). Validity indices of the King-Devick concussion test in hockey players. Clinical Journal of Sport Medicine, 32(3), e313-e315. PubMed Farnsworth, J. L., Dargo, L., Ragan, B. G., et al. (2017). Reliability of computerized neurocognitive tests for concussion assessment: a meta-analysis. Journal of Athletic Training, 52(9), 826-833. PubMed Wilmoth, K., Brett, B. L., Emmert, N. A., et al. (2023). Psychometric properties of computerized cognitive tools and standard neuropsychological tests used to assess sport concussion: a systematic review. Neuropsychology Review, 33(4), 675-692. PubMed Dretsch, M., Parish, R., Kelly, M., et al. (2015). Eight-day temporal stability of the Automated Neuropsychological Assessment Metric (ANAM) in a deployment environment. Applied Neuropsychology: Adult, 22(4), 304-310. PubMed Tenney, J. R., Gloss, D., Arya, R., et al. (2021). Practice guideline: use of quantitative EEG for the diagnosis of mild traumatic brain injury. Report of the Guideline Committee of the American Clinical Neurophysiology Society. Journal of Clinical Neurophysiology, 38(4), 287-292. PubMed Lindsey, H. M., Hodges, C. B., Greer, K. M., et al. (2023). Diffusion-weighted imaging in mild traumatic brain injury: a systematic review of the literature. Neuropsychology Review, 33(1), 42-121. PubMed Mayer, A. R., Bellgowan, P. S., & Hanlon, F. M. (2015). Functional magnetic resonance imaging of mild traumatic brain injury. Neuroscience and Biobehavioral Reviews, 49, 8-18. PubMed Huang, M., Lewine, J. D., & Lee, R. R. (2020). Magnetoencephalography for mild traumatic brain injury and posttraumatic stress disorder. Neuroimaging Clinics of North America, 30(2), 175-192. PubMed Hageman, G., Hof, J., Nihom, J., et al. (2022). Susceptibility-weighted MRI and microbleeds in mild traumatic brain injury: prediction of posttraumatic complaints? European Neurology, 85(3), 177-185. PubMed Eisele, A., Hill-Strathy, M., Michels, L., et al. (2020). Magnetic resonance spectroscopy following mild traumatic brain injury: a systematic review and meta-analysis on the potential to detect posttraumatic neurodegeneration. Neurodegenerative Diseases, 20(1), 2-11. PubMed Hamer, J., Churchill, N. W., Hutchison, M. G., et al. (2020). Sex differences in cerebral blood flow associated with a history of concussion. Journal of Neurotrauma, 37(10), 1197-1203. PubMed Alosco, M. L., Mariani, M. L., Adler, C. H., et al. (2021). Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project. Alzheimer's Research and Therapy, 13(1), 136. PubMed Maas, A. I. R., Menon, D. K., Manley, G. T., et al. (2022). Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurology, 21(11), 1004-1060. PubMed Silverberg, N. D., Iaccarino, M. A., Panenka, W. J., et al. (2020). Management of concussion and mild traumatic brain injury: a synthesis of practice guidelines. Archives of Physical Medicine and Rehabilitation, 101(2), 382-393. PubMed